產品詳情
簡單介紹：
Anti-C6orf203抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C6orf203抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-C6orf203
Cat. Number:
Anti-C6orf203抗體KL-15237R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposesAnti-C6orf203抗體 an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf203 gene product has been provisionally designated C6orf203 pending further characterization.
Also known as:
Chromosome 6 open reading Anti-C6orf203抗體frame 203; HSPC230; PRED31; RP11-59I9.1; Uncharacterized protein C6orf203; CF203_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C6orf203 .
●
Predicted Molecular Weight: 28kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-C6orf203抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-C6orf203抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-C6orf203抗體 must be determined by the end user.
kl803Mu02 神經介素B(NMB)多克隆抗體 Polyclonal Antibody to Neuromedin B (NMB)
kl810Mu02 心肌營養素1(CT1)多克隆抗體 Polyclonal Antibody to Cardiotrophin 1 (CT1)
kl812Mu02 胰淀素(IAPP)多克隆抗體 Polyclonal Antibody to Islet Amyloid Polypeptide (IAPP)
kl816Mu02 α1-酸性糖蛋白(α1AGP)多克隆抗體 Polyclonal Antibody to Alpha-1-Acid Glycoprotein (a1AGP)
kl817Mu02 結合珠蛋白(Hpt)多克隆抗體 Polyclonal Antibody to Haptoglobin (Hpt)
kl819Bo01 甲狀旁腺**相關蛋白(PTHrP)多克隆抗體 Polyclonal Antibody to klathyroid Hormone Related Protein (PTHrP)
kl819Mu02 甲狀旁腺**相關蛋白(PTHrP)多克隆抗體 Polyclonal Antibody to klathyroid Hormone Related Protein (PTHrP)
kl821Mu02 C反應蛋白(CRP)多克隆抗體 Polyclonal Antibody to C Reactive Protein (CRP)
kl822Mu02 60kD熱休克蛋白(HSPD1)多克隆抗體 Polyclonal Antibody to Heat Shock 60kD Protein 1, Chaperonin (HSPD1)
kl823Mu02 90kDa熱休克蛋白β1(HSP90β1)多克隆抗體 Polyclonal Antibody to Heat Shock Protein 90kDa Beta 1 (HSP90b1)
kl827Mu02 腫瘤壞死因子配體超家族成員14(TNFSF14)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 14 (TNFSF14)
kl833Mu02 血管性血友病因子(vWF)多克隆抗體 Polyclonal Antibody to Von Willebrand Factor (vWF)
kl834Mu02 凝血因子Ⅹ(F10)多克隆抗體 Polyclonal Antibody to Coagulation Factor X (F10)
kl839Mu02 促甲狀腺素釋放**(TRH)多克隆抗體 Polyclonal Antibody to Thyrotropin Releasing Hormone (TRH)
kl840Mu02 凝血因子Ⅸ(F9)多克隆抗體 Polyclonal Antibody to Coagulation Factor IX (F9)
kl841Mu02 含血管性血友病因子A域蛋白1(vWA1)多克隆抗體 Polyclonal Antibody to Von Willebrand Factor A Domain Containing Protein 1 (vWA1)
kl843Mu02 促性腺**釋放**(GnRH)多克隆抗體 Polyclonal Antibody to Gonadotropin Releasing Hormone (GnRH)
kl846Mu02 催乳素(PRL)多克隆抗體 Polyclonal Antibody to Prolactin (PRL)
kl847Mu02 抵抗素(RETN)多克隆抗體 Polyclonal Antibody to Resistin (RETN)
kl849Mu02 糖原磷酸化酶L(PYGL)多克隆抗體 Polyclonal Antibody to Glycogen Phosphorylase, Liver (PYGL)
kl852Mu02 蛋白酶激活受體2(kl2)多克隆抗體 Polyclonal Antibody to Protease Activated Receptor 2 (kl2)
kl853Mu02 胱天蛋白酶8(CASP8)多克隆抗體 Polyclonal Antibody to Caskle 8 (CASP8)
